Paget's disease of the breast differential diagnosis: Difference between revisions
Preeti Singh (talk | contribs) No edit summary |
Preeti Singh (talk | contribs) No edit summary |
||
Line 26: | Line 26: | ||
! rowspan="5" |Benign or Malignant | ! rowspan="5" |Benign or Malignant | ||
! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology | ! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology | ||
! colspan=" | ! colspan="9" |Clinical manifestations | ||
! colspan="2" rowspan="2" |Para-clinical findings | ! colspan="2" rowspan="2" |Para-clinical findings | ||
| rowspan="5" |Gold Standard | | rowspan="5" |Gold Standard | ||
Line 32: | Line 32: | ||
|- | |- | ||
! colspan="6" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Symptoms | ! colspan="6" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Symptoms | ||
! colspan=" | ! colspan="3" rowspan="2" |Physical examination | ||
|- | |- | ||
!Lab Findings | !Lab Findings | ||
Line 40: | Line 40: | ||
! colspan="1" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Itching | ! colspan="1" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Itching | ||
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Mastalgia | ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Mastalgia | ||
! rowspan="2" |Breast Exam | |||
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other | ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other | ||
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Serum IgE | ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Serum IgE | ||
Line 69: | Line 70: | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" | – | | align="center" style="background:#F5F5F5;" | – | ||
| | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Centrofacial pallor | * Centrofacial pallor | ||
Line 108: | Line 110: | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Stinging and burning | * Stinging and burning | ||
Line 133: | Line 136: | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* [[Swelling]], [[Blister|blistering]] and scaling of the damaged area | * [[Swelling]], [[Blister|blistering]] and scaling of the damaged area | ||
Line 163: | Line 167: | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* [[Auspitz's sign]] (pinpoint bleeding) | * [[Auspitz's sign]] (pinpoint bleeding) | ||
Line 191: | Line 196: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
** | ** | ||
| | |||
| align="center" style="background:#F5F5F5;" | Nl | | align="center" style="background:#F5F5F5;" | Nl | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 196: | Line 202: | ||
* Psoriasiform [[hyperplasia]] | * Psoriasiform [[hyperplasia]] | ||
* [[Neutrophils]] at the margins | * [[Neutrophils]] at the margins | ||
| | | align="center" style="background:#F5F5F5;" |Risk factors include | ||
* [[Stress]] | * [[Stress]] | ||
Line 202: | Line 208: | ||
* [[Superinfection]] with bacteria and [[candida]] | * [[Superinfection]] with bacteria and [[candida]] | ||
Generalized seborrheic [[erythroderma]] in immunodeficient patients | Generalized seborrheic [[erythroderma]] in immunodeficient patients | ||
| | |||
| | |||
|- | |- | ||
![[Melanoma|Malignant melanoma]] | ![[Melanoma|Malignant melanoma]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 220: | Line 229: | ||
|- | |- | ||
![[Bowen’s disease]] | ![[Bowen’s disease]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 236: | Line 246: | ||
|- | |- | ||
![[Basal cell carcinoma|Superficial basal cell carcinoma]] | ![[Basal cell carcinoma|Superficial basal cell carcinoma]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 252: | Line 263: | ||
|- | |- | ||
![[Basal cell carcinoma|Pagetoid basal cell carcinoma]] | ![[Basal cell carcinoma|Pagetoid basal cell carcinoma]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 268: | Line 280: | ||
|- | |- | ||
![[Intraductal papilloma|Benign intraductal papilloma]] | ![[Intraductal papilloma|Benign intraductal papilloma]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 284: | Line 297: | ||
|- | |- | ||
!Pagetoid dyskeratosis | !Pagetoid dyskeratosis | ||
! | |||
! | ! | ||
! | ! | ||
Line 304: | Line 318: | ||
* Common among [[perimenopausal]]<nowiki/>women | * Common among [[perimenopausal]]<nowiki/>women | ||
* Usually resolve spontaneously | * Usually resolve spontaneously | ||
! | |||
! | ! | ||
! | ! | ||
Line 318: | Line 333: | ||
|- | |- | ||
!Nipple duct adenoma | !Nipple duct adenoma | ||
! | |||
! | ! | ||
! | ! | ||
Line 334: | Line 350: | ||
|- | |- | ||
!Benign Toker cell hyperplasia | !Benign Toker cell hyperplasia | ||
! | |||
! | ! | ||
! | ! | ||
Line 359: | Line 376: | ||
! | ! | ||
!+ | !+ | ||
! | |||
! | ! | ||
! | ! | ||
Line 366: | Line 384: | ||
|- | |- | ||
![[Mondors disease]] | ![[Mondors disease]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 382: | Line 401: | ||
|- | |- | ||
![[Breast abscess]] | ![[Breast abscess]] | ||
! | ! | ||
* [[Benign]] | |||
* No increased risk of [[malignancy]] | |||
! | ! | ||
! | ! | ||
Line 391: | Line 411: | ||
! | ! | ||
!+ | !+ | ||
!± | |||
! | ! | ||
* [[Breast]][[tenderness]] | |||
* Swollen [[breast]][[tissue]] | |||
! | ! | ||
! | ! | ||
! | ! | ||
[[Breast]] [[parenchyma]][[inflammation]]: | |||
* [[Acute]] [[mastitis]]: [[Staphylococcus]] [[infection]] | |||
* [[Granulomatous]] [[mastitis]]: [[Tuberculosis]] or [[sarcoidosis]][[infection]] | |||
! | ! | ||
| | |||
|- | |- | ||
Revision as of 22:04, 20 February 2019
Paget's disease of the breast Microchapters |
Differentiating Paget's disease of the breast from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Paget's disease of the breast differential diagnosis On the Web |
American Roentgen Ray Society Images of Paget's disease of the breast differential diagnosis |
Paget's disease of the breast differential diagnosis in the news |
Blogs on Paget's disease of the breast differential diagnosis |
Directions to Hospitals Treating Paget's disease of the breast |
Risk calculators and risk factors for Paget's disease of the breast differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Suveenkrishna Pothuru, M.B,B.S. [2]
Overview
Paget's disease of the breast must be differentiated from atopic dermatitis, eczema, psoriasis, malignant melanoma, Bowen's disease, basal cell carcinoma, and pagetoid dyskeratosis.[1][2]
Differential Diagnosis
Paget’s disease of the breast must be differentiated from other benign and malignant processes of nipple-areola complex such as:[1][2]
- Atopic dermatitis
- Chronic contact dermatitis
- Lactiferous duct ectasia
- Chronic eczema
- Psoriasis
- Nipple duct adenoma
- Malignant melanoma
- Bowen’s disease
- Superficial basal cell carcinoma
- Pagetoid basal cell carcinoma
- Benign intraductal papilloma
- Pagetoid dyskeratosis
Category | Diseases | Benign or Malignant | Etiology | Clinical manifestations | Para-clinical findings | Gold Standard | Associated factors | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Physical examination | ||||||||||||||||
Lab Findings | Histopathology | ||||||||||||||||
Appearance | Itching | Mastalgia | Breast Exam | Other | Serum IgE | ||||||||||||
Single/
Multiple |
Rash | Involved areas | Nipple
DIscharge |
Erythema | |||||||||||||
Skin disorders | Atopic dermatitis | Benign |
|
Multiple |
|
– | + | – |
|
↑ |
|
| |||||
Allergic contact dermatitis[3] | Benign |
|
May be multiple after 1-2 days of exposure | Erythematous well-demarcated papules | Surrounding the area in contact with the offending agent | – | + | + |
|
Nl |
|
| |||||
Irritant contact dermatitis[4] | Benign |
|
Usually single immediately after the exposure | Well-demarcated red patch with a glazed surface | Any area in contact with the irritant | – | + | + |
|
Nl |
|
| |||||
Psoriasis | Benign |
|
Multiple | Well-circumscribed, pink papules and symmetrically distributed cutaneous plaques with silvery scales |
|
+ | + | + |
|
Nl |
|
Risk factors include
| |||||
Chronic eczema | Benign |
|
Scalp, face, trunk, postauricular, diaper area and axilla | + | + | – |
|
Nl |
|
Risk factors include
Generalized seborrheic erythroderma in immunodeficient patients |
|||||||
Malignant melanoma | |||||||||||||||||
Bowen’s disease | |||||||||||||||||
Superficial basal cell carcinoma | |||||||||||||||||
Pagetoid basal cell carcinoma | |||||||||||||||||
Benign intraductal papilloma | |||||||||||||||||
Pagetoid dyskeratosis | |||||||||||||||||
Lactiferous duct ectasia | Benign |
|
|||||||||||||||
Nipple duct adenoma | |||||||||||||||||
Benign Toker cell hyperplasia | |||||||||||||||||
Mastitis | Benign | + | |||||||||||||||
Mondors disease | |||||||||||||||||
Breast abscess |
|
+ | ± |
|
References
- ↑ 1.0 1.1 Gaspari, Eleonora; Ricci, Aurora; Liberto, Valeria; Scarano, Angela Lia; Fornari, Maria; Simonetti, Giovanni (2013). "An Unusual Case of Mammary Paget's Disease Diagnosed Using Dynamic Contrast-Enhanced MRI". Case Reports in Radiology. 2013: 1–5. doi:10.1155/2013/206235. ISSN 2090-6862.
- ↑ 2.0 2.1 Lopes Filho, Lauro Lourival; Lopes, Ione Maria Ribeiro Soares; Lopes, Lauro Rodolpho Soares; Enokihara, Milvia M. S. S.; Michalany, Alexandre Osores; Matsunaga, Nobuo (2015). "Mammary and extramammary Paget's disease". Anais Brasileiros de Dermatologia. 90 (2): 225–231. doi:10.1590/abd1806-4841.20153189. ISSN 1806-4841.
- ↑ Nosbaum A, Vocanson M, Rozieres A, Hennino A, Nicolas JF (2009). "Allergic and irritant contact dermatitis". Eur J Dermatol. 19 (4): 325–32. doi:10.1684/ejd.2009.0686. PMID 19447733.
- ↑ Bains SN, Nash P, Fonacier L (October 2018). "Irritant Contact Dermatitis". Clin Rev Allergy Immunol. doi:10.1007/s12016-018-8713-0. PMID 30293200.